List of authorized vaccines and treatments for COVID-19

Product name Company name Product type Status Date of approval Approved for different indication ID
EVUSHELD (cilgavimab / tixagevimab) AstraZeneca Canada Inc. Treatment Authorized No 109
Covifenz (virus-like particles (VLP) of SARS-CoV-2 spike protein) Medicago Inc Vaccine Authorized No 106
NUVAXOVID (SARS-CoV-2 recombinant spike protein) Novavax Inc Vaccine Authorized No 104
PAXLOVID (nirmatrelvir / ritonavir) Pfizer Canada ULC Treatment Authorized No 102
Sotrovimab (sotrovimab) GlaxoSmithKline Inc Treatment Authorized By Interim Order No 36
Casirivimab and imdevimab (casirivimab / imdevimab) Hoffmann-La Roche Limited Treatment Authorized By Interim Order No 34
Janssen COVID-19 Vaccine (Ad26.COV2.S [recombinant]) Janssen Inc Vaccine Authorized By Interim Order No 27
COVISHIELD (ChAdOx1-S [recombinant]) Expired September 16 2021 Verity Pharmaceuticals Inc/Serum Institute of India (in partnership with AstraZeneca Canada Inc) Vaccine Authorized By Interim Order No 29
Vaxzevria (ChAdOx1-S [recombinant]) previously Astrazeneca Covid-19 Vaccine AstraZeneca Canada Inc. Vaccine Authorized By Interim Order No 28
SPIKEVAX (elasomeran) previously COVID-19 Vaccine Moderna ModernaTX, Inc. Vaccine Authorized By Interim Order No 15
Comirnaty (tozinameran) previously Pfizer-BioNTech COVID-19 Vaccine BioNTech Manufacturing GmbH Vaccine Authorized By Interim Order No 16
Bamlanivimab (bamlanivimab) Eli Lilly Canada Inc Treatment Authorized By Interim Order No 8
Veklury (remdesivir) Gilead Sciences Canada Inc Treatment Authorized No 9